Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB for Polymyalgia rheumatica: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 964 adverse event reports in the FDA FAERS database where TOCILIZUMAB was used for Polymyalgia rheumatica.

Most Reported Side Effects for TOCILIZUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 32,342 32.9% 1,812 6,486
Rheumatoid arthritis 20,652 21.0% 2,125 5,176
Pain 18,384 18.7% 1,939 4,934
Off label use 18,256 18.5% 3,347 5,844
Arthralgia 15,536 15.8% 1,996 4,784
Joint swelling 14,831 15.1% 2,093 4,081
Fatigue 13,802 14.0% 2,217 4,295
Rash 12,327 12.5% 2,019 4,046
Drug intolerance 11,952 12.1% 1,587 3,341
Contraindicated product administered 11,547 11.7% 1,409 3,008
Arthropathy 9,816 10.0% 1,774 3,868
Alopecia 9,680 9.8% 1,726 2,784
Abdominal discomfort 9,553 9.7% 1,715 2,821
Synovitis 9,428 9.6% 1,890 3,599
Swelling 9,420 9.6% 1,850 2,910

Other Indications for TOCILIZUMAB

Rheumatoid arthritis (55,449) Product used for unknown indication (21,090) Giant cell arteritis (4,364) Covid-19 (4,186) Juvenile idiopathic arthritis (2,016) Covid-19 pneumonia (1,583) Still's disease (1,418) Temporal arteritis (1,269) Cytokine release syndrome (735) Systemic lupus erythematosus (446)

Other Drugs Used for Polymyalgia rheumatica

SARILUMAB (1,963) PREDNISOLONE (439) PREDNISONE (393) METHOTREXATE (369) ETANERCEPT (100) ADALIMUMAB (73) METHYLPREDNISOLONE (63) TOFACITINIB (41) PREGABALIN (33) DENOSUMAB (28)

Related Pages

TOCILIZUMAB Full Profile All Polymyalgia rheumatica Drugs TOCILIZUMAB Demographics TOCILIZUMAB Timeline